Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Novel agents for irritable bowel syndrome in early development at Kyorin

Sep. 1, 1998

Chugai investigates macrolide compounds as prokinetic agents

Sep. 1, 1998

FDA approves first treatment for Crohn's disease

Aug. 27, 1998

Rebetron receives priority review status

Aug. 26, 1998

First approval for lamivudine in chronic hepatitis B

Aug. 25, 1998

Il Yang synthesizes gastric H+/K+-ATPase inhibitors with improved stability

Aug. 25, 1998

New agents for pancreatitis in early development at Sankyo

Aug. 25, 1998

Thymosin alpha 1 receives patent protection for hepatitis C indication

Aug. 24, 1998

Nabi files PLA, ELA for hepatitis B immune globulin

Aug. 21, 1998

New clinical study evaluating INKP-100 now in progress

Aug. 21, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...